Identification and extensive analysis of inverted-duplicated HBV integration in a human hepatocellular carcinoma cell line

키워드

참고문헌 (36)

1. Bonilla Guerrero, R., "The role of hepatitis B virus integrations in the pathogenesis of human hepatocellular carcinoma", J. Hepatol., 42, pp.760~777 (2005)
2. Matsubara, K., "Integration of hepatitis B virus DNA and its implications for hepatocarcinogenesis", Mol. Biol. Med., 7, pp.243~260 (1990)
3. Tsai, W. L., "Viral hepatocarcinogenesis", Oncogene, 29, pp.2309~2324 (2010)
4. Wollersheim, M., "A transactivating function encoded in the hepatitisB virus X gene is conserved in the integrated state", Oncogene, 3, pp.545~552 (1988)
5. Brechot, C., "Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms", Gastroenterology, 127, pp.S56~S61 (2004)
6. Gozuacik, D., "Identification of human cancer-related genes by naturally occurring Hepatitis B Virus DNA tagging", Oncogene, 20, pp.6233~6240 (2001)
7. Minami, M., "Hepatitis B virus-related insertional mutagenesis in chronic hepatitis B patients as an early drastic genetic change leading to hepatocarcinogenesis", Oncogene, 24, pp.4340~4348 (2005)
8. Horikawa, I., "cis-Activation of the human telomerase gene (hTERT) by the hepatitis B virus genome", J. Natl. Cancer. Inst., 93, pp.1171~1173 (2001)
9. Feitelson, M. A., "Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis", Cancer. Lett., 252, pp.157~170 (2007)
10. Murakami, Y., "Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues", Oncogene, 25, pp.2537~2545 (2006)
11. Wang, J., "Modification of cyclin A expression by hepatitis B virus DNA integration in a hepatocellular carcinoma", Oncogene, 7, pp.1653~1656 (1992)
12. Paterlini-Brechot, P., "Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene", Oncogene, 22, pp.3911~3916 (2003)
13. Murakami, Y., "Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas", Gut, 54, pp.1162~1168 (2005)
14. Glover, T. W., "Common fragile sites", Cancer. Lett., 232, pp.4~12 (2006)
15. Ahn, S. H., "Molecular and Clinical Characteristics of Hepatitis B Virus in Korea", Journal Of Medical Virology, 82(7), pp.1126~1134 (2010), WILEY-LISS
16. Norder, H., "Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes", Intervirology, 47, pp.289~309 (2004)
17. Hatada, I., "Co-amplification of integrated hepatitis B virusDNA and transforming gene hst-1 in a hepatocellularcarcinoma", Oncogene, 3, pp.537~540 (1988)
18. Tokino, T., "Chromosomal sites for hepatitis B virus integration in human hepatocellular carcinoma", J. Virol., 65, pp.6761~6764 (1991)
19. Tamori, A., "Hepatitis B virus DNA integration in hepatocellular carcinoma after interferon-induced disappearance of hepatitis C virus", Am. J. Gastroenterol., 100, pp.1748~1753 (2005)
20. Luo, M. L., "Amplification and overexpression of CTTN (EMS1) contribute to the metastasis of esophageal squamous cell carcinoma by promoting cell migration and anoikis resistance", Cancer. Res., 66, pp.11690~11699 (2006)
21. Kusano, N., "Genetic aberrations detected by comparative genomic hybridization in hepatocellular carcinomas: their relationship to clinicopathological features", Hepatology, 29, pp.1858~1862 (1999)
22. Chen, C. F., "Overlapping high-resolution copy number alterations in cancer genomes identified putative cancer genes in hepatocellular carcinoma", Hepatology, 52, pp.1690~1701 (2010)
23. Sawey, E. T., "Identification of a therapeutic strategy targeting amplified FGF19 in liver cancer by Oncogenomic screening", Cancer. Cell., 19, pp.347~358 (2011)
24. Ornitz, D. M., "Fibroblast growth factors", Genome. Biol., 2 (2001)
25. Nicholes, K., "A mouse model of hepatocellular carcinoma: ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice", Am. J. Pathol., 160, pp.2295~2307 (2002)
26. Pai, R., "Inhibition of fibroblast growth factor 19 reduces tumor growth by modulating beta-catenin signaling", Cancer. Res., 68, pp.5086~5095 (2008)
27. Miura, S., "Fibroblast growth factor 19 expression correlates with tumor progression and poorer prognosis of hepatocellular carcinoma", BMC. cancer., 12, pp.56~ (2012)
28. Buschges, R., "Amplification and expression of cyclin D genes (CCND1, CCND2 and CCND3) in human malignant gliomas", Brain. Pathol., 9, pp.432~442 (1999)
29. Wessendorf, S., "Hidden gene amplifications in aggressive B-cell non-Hodgkin lymphomas detected by microarray-based comparative genomic hybridization", Oncogene, 22, pp.1425~1429 (2003)
30. Huang, X., "High-resolution mapping of the 11q13 ampliconand identification of a gene, TAOS1, that is amplified andoverexpressed in oral cancer cells", Proc. Natl. Acad. Sci.USA., 99, pp.11369~11374 (2002)
31. Nishida, N., "Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma", Cancer. Res., 54, pp.3107~3110 (1994)
32. Shamay, M., "HBV integrants of hepatocellular carcinoma cell lines contain an active enhancer", Oncogene, 20, pp.6811~6819 (2001)
33. Park, J. G., "Characterization of cell lines established from human hepatocellular carcinoma", Int. J. Cancer., 62, pp.276~282 (1995)
34. Lee, J. H., "Establishment and characterization of four human hepatocellular carcinoma cell lines containing hepatitis B virus DNA", World. J. Gastroenterol., 5, pp.289~295 (1999)
35. Asakawa, S., "Human BAC library: construction and rapid screening", Gene, 191, pp.69~79 (1997)
36. Schmittgen, T. D., "Analyzing real- time PCR data by the comparative C(T) method", Nat. Protoc., 3, pp.1101~1108 (2008)

관련 논문AI추천